Europe Endomyocardial Biopsy Devices Market Size and Forecast (2021

Description

List of Tables

The Europe Endomyocardial Biopsy Devices Market is projected to grow from US$ 105,371.7 Thousand in 2025 to US$ 146,794.0 Thousand by 2034. The market is anticipated to register a CAGR of 3.8% during the forecast period from 2026 to 2034.

Executive Summary and Europe Endomyocardial Biopsy Devices Market Analysis

Significant progress in cardiac regenerative medicine and precision-based delivery technologies is contributing substantially to the growth of the European endomyocardial biopsy devices market. For instance, CellProthera's acquisition in February 2026 of a transendocardial catheter originally developed by Celyad Oncology highlights the increasing convergence between medical device innovation and therapeutic advancement. These catheter technologies support the precise administration of therapies, including CD34+ stem cells, directly into damaged myocardial tissue, potentially offering greater therapeutic effectiveness than systemic delivery methods.

As regenerative medicine and cell-based cardiac therapies advance toward late-stage development and pivotal Phase 3 clinical trials, the need for specialized biopsy and catheter-based technologies is increasing. Endomyocardial biopsy devices serve a dual role by supporting tissue collection for diagnostic evaluation while also becoming increasingly integrated with therapeutic delivery platforms. Consequently, these devices are emerging as important tools in the development and implementation of next-generation cardiac treatment approaches.

Strategic Insights

Europe Endomyocardial Biopsy Devices Market Segmentation Analysis

By Product Type, the Europe Endomyocardial Biopsy Devices Market is categorized into Biopsy Forceps and Catheters, Guidance Systems, and Accessories. Among these, the Biopsy Forceps and Catheters segment accounted for the largest market share in 2025.

By Biopsy Forceps and Catheters, the market is divided into Standard Endomyocardial Biopsy Forceps and Flexible Biopsy Catheters. The Standard Endomyocardial Biopsy Forceps segment held the dominant position in 2025.

By Guidance Systems, the market is segmented into Fluoroscopy-guided Systems, Echocardiography-guided Systems, and Emerging Robotic Navigation Systems. The Fluoroscopy-guided Systems segment represented the leading share in 2025.

By Accessories, the market includes Introducer Sheaths, Guidewires, and Localization Tools. The Introducer Sheaths segment dominated the market in 2025.

By Guidance Technique, the market is classified into Fluoroscopy-guided EMB, Echocardiography-guided EMB, and Hybrid Techniques. The Fluoroscopy-guided EMB segment held the largest share in 2025.

By Application, the Europe Endomyocardial Biopsy Devices Market is segmented into Transplant Rejection Monitoring, Myocarditis Diagnosis, Cardiomyopathy Evaluation, and Other Cardiac Pathologies. The Transplant Rejection Monitoring segment led the market in 2025.

By End User, the market is categorized into Cardiac Centers and Hospitals, Diagnostic and Research Institutes, and Academic Institutions. The Cardiac Centers and Hospitals segment accounted for the largest market share in 2025.

Market Report Scope

Europe Endomyocardial Biopsy Devices Market Outlook

The increasing prevalence of cardiovascular diseases (CVDs), including myocarditis, cardiomyopathy, and other structural cardiac disorders, is a major factor supporting the expansion of the endomyocardial biopsy devices market. Several of these conditions are associated with nonspecific clinical manifestations, creating challenges in establishing an accurate diagnosis. Although diagnostic imaging techniques such as echocardiography and magnetic resonance imaging (MRI) can provide valuable structural information, definitive assessment may require direct myocardial tissue examination through endomyocardial biopsy (EMB). Tissue analysis enables clinicians to identify inflammation, fibrosis, and infiltrative abnormalities that may not be fully characterized through noninvasive techniques.

Myocarditis, which involves inflammation of the cardiac muscle, may require histopathological assessment for confirmation in appropriate clinical settings. Similarly, specific forms of cardiomyopathy, particularly restrictive and infiltrative cardiomyopathies, can require tissue sampling to distinguish between different underlying causes and determine suitable treatment strategies. This diagnostic requirement is expected to support continued demand for endomyocardial biopsy devices across hospitals, specialized cardiac facilities, and transplant centers as the burden of cardiovascular disease increases.

The substantial global cardiovascular disease burden further highlights the potential for market expansion. Data from the Institute for Health Metrics and Evaluation (IHME) indicate that cardiovascular diseases remained the leading contributor to disability-adjusted life years (DALYs) and deaths globally in 2023. Approximately 437 million CVD DALYs were reported worldwide in 2023, with a 95% uncertainty interval of 401-465 million. Major contributors included ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease. Global CVD-related deaths also increased from approximately 13.1 million in 1990 to 19.2 million in 2023, with a 95% uncertainty interval of 17.4-20.4 million. This expanding disease burden represents a growing population requiring advanced diagnostic procedures and supports the long-term opportunity for EMB devices.

The importance of endomyocardial biopsy extends beyond the increasing number of cardiovascular cases. Complex conditions such as inflammatory, infiltrative, and genetic cardiomyopathies often require tissue-based evaluation for initial diagnosis, disease monitoring, and assessment of treatment effectiveness. Identification of myocardial inflammation or fibrotic alterations can assist physicians in determining appropriate management approaches, including immunosuppressive treatment, antiviral therapy, or heart failure interventions.

With healthcare systems increasingly emphasizing personalized and evidence-based treatment, endomyocardial biopsy devices are gaining importance because they provide histopathological information that cannot always be obtained through noninvasive diagnostic modalities. Therefore, the combination of rising cardiovascular disease prevalence and evolving approaches to diagnosis and disease management is expected to sustain the adoption of endomyocardial biopsy devices across global healthcare markets.

Europe Endomyocardial Biopsy Devices Market Country Insights

Based on country, the Europe Endomyocardial Biopsy Devices Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany accounted for the largest market share in 2025.

The German endomyocardial biopsy devices market benefits from the country's sophisticated healthcare infrastructure, alignment with European regulatory requirements, and extensive network of specialized cardiac care facilities. Medical device regulation and oversight involve the Federal Institute for Drugs and Medical Devices (BfArM), together with the broader European regulatory environment established through the European Medicines Agency (EMA) and the European Union Medical Device Regulation (MDR). These frameworks impose stringent requirements related to product safety, clinical evidence, and validation.

Germany's established medical technology sector and strong emphasis on healthcare innovation also encourage the adoption of advanced diagnostic and interventional cardiology technologies. Organizations such as the German Cardiac Society contribute to the advancement and adoption of modern cardiac care practices, including biopsy-supported procedures. In addition, the presence of major domestic and international medical technology companies, including Siemens Healthineers and B. Braun Melsungen AG, supports continued development of catheter-based technologies and imaging integration.

The country's substantial cardiac procedure volume, rising burden of heart failure, and growing focus on precision medicine are further contributing to demand for minimally invasive biopsy technologies. These devices enable accurate myocardial tissue assessment and support ongoing monitoring following transplantation, thereby strengthening their role within Germany's advanced cardiac care ecosystem.

Europe Endomyocardial Biopsy Devices Market Company Profiles

Key companies operating in the Europe Endomyocardial Biopsy Devices Market include Terumo Corp, Argon Medical Devices, Koninklijke Philips NV, GE HealthCare Technologies Inc., Siemens Healthineers AG, Cordis Corp, Scholten Surgical Instruments, Inc., Changzhou Lookmed Medical Instrument Co., Ltd., FEHLING INSTRUMENTS GmbH, and WILDmedical GmbH.

Market participants are pursuing a range of strategic initiatives, including geographic expansion, new product development, technological innovation, mergers, and acquisitions. These strategies are aimed at strengthening product portfolios, addressing evolving clinical requirements, expanding customer reach, and increasing overall market presence.

Product Code: TIPRE00043894

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Endomyocardial Biopsy Devices Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. Europe Endomyocardial Biopsy Devices Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Endomyocardial Biopsy Devices Market - Europe Analysis

5.1 Europe Endomyocardial Biopsy Devices Market Revenue (US$ Thousand), 2021 - 2034
5.2 Europe Endomyocardial Biopsy Devices Market Revenue Forecast and Analysis

6. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by Product Type

6.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by Product Type
- 6.1.1 Biopsy Forceps and Catheters
  - 6.1.1.1 Overview
  - 6.1.1.2 Biopsy Forceps and Catheters: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 6.1.2 Guidance Systems
  - 6.1.2.1 Overview
  - 6.1.2.2 Guidance Systems: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 6.1.3 Accessories
  - 6.1.3.1 Overview
  - 6.1.3.2 Accessories: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

7. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by Biopsy Forceps And Catheters

7.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by Biopsy Forceps And Catheters
- 7.1.1 Standard endomyocardial biopsy forceps
  - 7.1.1.1 Overview
  - 7.1.1.2 Standard endomyocardial biopsy forceps: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 7.1.2 Flexible biopsy catheters
  - 7.1.2.1 Overview
  - 7.1.2.2 Flexible biopsy catheters: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

8. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by Guidance Systems - Product Type

8.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by Guidance Systems - Product Type
- 8.1.1 Fluoroscopy-guided systems
  - 8.1.1.1 Overview
  - 8.1.1.2 Fluoroscopy-guided systems: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 8.1.2 Echocardiography-guided systems
  - 8.1.2.1 Overview
  - 8.1.2.2 Echocardiography-guided systems: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 8.1.3 Emerging robotic navigation systems
  - 8.1.3.1 Overview
  - 8.1.3.2 Emerging robotic navigation systems: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

9. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by Accessories

9.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by Accessories
- 9.1.1 Introducer sheaths
  - 9.1.1.1 Overview
  - 9.1.1.2 Introducer sheaths: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 9.1.2 Guidewires
  - 9.1.2.1 Overview
  - 9.1.2.2 Guidewires: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 9.1.3 Localization tools
  - 9.1.3.1 Overview
  - 9.1.3.2 Localization tools: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

10. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by Guidance Technique

10.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by Guidance Technique
- 10.1.1 Fluoroscopy-guided EMB
  - 10.1.1.1 Overview
  - 10.1.1.2 Fluoroscopy-guided EMB: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 10.1.2 Echocardiography-guided EMB
  - 10.1.2.1 Overview
  - 10.1.2.2 Echocardiography-guided EMB: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 10.1.3 Hybrid techniques
  - 10.1.3.1 Overview
  - 10.1.3.2 Hybrid techniques: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

11. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by Application

11.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by Application
- 11.1.1 Transplant rejection monitoring
  - 11.1.1.1 Overview
  - 11.1.1.2 Transplant rejection monitoring: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 11.1.2 Myocarditis diagnosis
  - 11.1.2.1 Overview
  - 11.1.2.2 Myocarditis diagnosis: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 11.1.3 Cardiomyopathy evaluation
  - 11.1.3.1 Overview
  - 11.1.3.2 Cardiomyopathy evaluation: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 11.1.4 Other cardiac pathologies
  - 11.1.4.1 Overview
  - 11.1.4.2 Other cardiac pathologies: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

12. Europe Endomyocardial Biopsy Devices Market Revenue Analysis - by End User

12.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis by End User
- 12.1.1 Cardiac centers and hospitals
  - 12.1.1.1 Overview
  - 12.1.1.2 Cardiac centers and hospitals: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 12.1.2 Diagnostic and research institutes
  - 12.1.2.1 Overview
  - 12.1.2.2 Diagnostic and research institutes: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
- 12.1.3 Academic institutions
  - 12.1.3.1 Overview
  - 12.1.3.2 Academic institutions: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)

13. Europe Endomyocardial Biopsy Devices Market - Country Analysis

13.1 Europe
- 13.1.1 Europe Endomyocardial Biopsy Devices Market Forecast and Analysis - by Country
  - 13.1.1.1 Germany Market
    - 13.1.1.1.1 Germany: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.1.2 Germany: Europe Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.1.2.1 Product Type
      - 13.1.1.1.2.2 Biopsy Forceps And Catheters
      - 13.1.1.1.2.3 Guidance Systems - Product Type
      - 13.1.1.1.2.4 Accessories
      - 13.1.1.1.2.5 Guidance Technique
      - 13.1.1.1.2.6 Application
      - 13.1.1.1.2.7 End User
  - 13.1.1.2 United Kingdom Market
    - 13.1.1.2.1 United Kingdom: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.2.2 United Kingdom: Europe Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.2.2.1 Product Type
      - 13.1.1.2.2.2 Biopsy Forceps And Catheters
      - 13.1.1.2.2.3 Guidance Systems - Product Type
      - 13.1.1.2.2.4 Accessories
      - 13.1.1.2.2.5 Guidance Technique
      - 13.1.1.2.2.6 Application
      - 13.1.1.2.2.7 End User
  - 13.1.1.3 France Market
    - 13.1.1.3.1 France: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.3.2 France: Europe Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.3.2.1 Product Type
      - 13.1.1.3.2.2 Biopsy Forceps And Catheters
      - 13.1.1.3.2.3 Guidance Systems - Product Type
      - 13.1.1.3.2.4 Accessories
      - 13.1.1.3.2.5 Guidance Technique
      - 13.1.1.3.2.6 Application
      - 13.1.1.3.2.7 End User
  - 13.1.1.4 Italy Market
    - 13.1.1.4.1 Italy: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.4.2 Italy: Europe Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.4.2.1 Product Type
      - 13.1.1.4.2.2 Biopsy Forceps And Catheters
      - 13.1.1.4.2.3 Guidance Systems - Product Type
      - 13.1.1.4.2.4 Accessories
      - 13.1.1.4.2.5 Guidance Technique
      - 13.1.1.4.2.6 Application
      - 13.1.1.4.2.7 End User
  - 13.1.1.5 Spain Market
    - 13.1.1.5.1 Spain: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.5.2 Spain: Europe Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.5.2.1 Product Type
      - 13.1.1.5.2.2 Biopsy Forceps And Catheters
      - 13.1.1.5.2.3 Guidance Systems - Product Type
      - 13.1.1.5.2.4 Accessories
      - 13.1.1.5.2.5 Guidance Technique
      - 13.1.1.5.2.6 Application
      - 13.1.1.5.2.7 End User
  - 13.1.1.6 Rest of Europe Market
    - 13.1.1.6.1 Rest of Europe: Europe Endomyocardial Biopsy Devices Market - Revenue and Forecast, 2021 - 2034 (US$ Thousand)
    - 13.1.1.6.2 Rest of Europe: Europe Endomyocardial Biopsy Devices Market - By Segmentation
      - 13.1.1.6.2.1 Product Type
      - 13.1.1.6.2.2 Biopsy Forceps And Catheters
      - 13.1.1.6.2.3 Guidance Systems - Product Type
      - 13.1.1.6.2.4 Accessories
      - 13.1.1.6.2.5 Guidance Technique
      - 13.1.1.6.2.6 Application
      - 13.1.1.6.2.7 End User

14 Endomyocardial Biopsy Devices Market Industry Landscape

15 - Key Company Profiles

15.1 Terumo Corp
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 Argon Medical Devices
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 Koninklijke Philips NV
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 GE HealthCare Technologies Inc
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 Siemens Healthineers AG
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 Cordis Corp
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 Scholten Surgical Instruments, Inc.
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 Changzhou Lookmed Medical Instrument Co., Ltd.
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 FEHLING INSTRUMENTS GmbH
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 WILDmedical GmbH
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments

16. Appendix

16.1 Glossary
16.2 Research Methodology and Approach
- 16.2.1 Secondary Research
- 16.2.2 Primary Research
- 16.2.3 Market Estimation Approach
  - 16.2.3.1 Supply Side Analysis
  - 16.2.3.2 Demand Side Analysis
- 16.2.4 Research Assumptions and Limitations
- 16.2.5 Currency Conversion
16.3 About The Insight Partners
16.4 Market Intelligence Cloud